Cargando…
Periodontal Regenerative Therapy Using rhFGF-2 and Deproteinized Bovine Bone Mineral versus rhFGF-2 Alone: 4-Year Extended Follow-Up of a Randomized Controlled Trial
The aim of this study was to evaluate longitudinal outcomes of recombinant human fibroblast growth factor (rhFGF)-2 plus deproteinized bovine bone mineral (DBBM) therapy in comparison with rhFGF-2 alone for treating periodontal intrabony defects. This study describes 4-year follow-up outcomes of the...
Autores principales: | Seshima, Fumi, Bizenjima, Takahiro, Aoki, Hideto, Imamura, Kentaro, Kita, Daichi, Irokawa, Daisuke, Matsugami, Daisuke, Kitamura, Yurie, Yamashita, Keiko, Sugito, Hiroki, Tomita, Sachiyo, Saito, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688011/ https://www.ncbi.nlm.nih.gov/pubmed/36421696 http://dx.doi.org/10.3390/biom12111682 |
Ejemplares similares
-
Periodontal surgery using rhFGF‐2 with deproteinized bovine bone mineral or rhFGF‐2 alone: 2‐year follow‐up of a randomized controlled trial
por: Aoki, Hideto, et al.
Publicado: (2020) -
Treatment of intrabony periodontal defects using rhFGF‐2 in combination with deproteinized bovine bone mineral or rhFGF‐2 alone: A 6‐month randomized controlled trial
por: Saito, Atsushi, et al.
Publicado: (2019) -
Efficient treatment of Parkinson’s disease using ultrasonography-guided rhFGF20 proteoliposomes
por: Niu, Jianlou, et al.
Publicado: (2018) -
Sprifermin (rhFGF18) modulates extracellular matrix turnover in cartilage explants ex vivo
por: Reker, Ditte, et al.
Publicado: (2017) -
Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/db and DIO mice
por: Zhao, Longwei, et al.
Publicado: (2017)